Wenckebach syndrome, formally known as Mobitz Type I second-degree atrioventricular (AV) block, represents a specific conduction abnormality within the heart's electrical system. This condition is characterized by a progressive lengthening of the PR interval on an electrocardiogram (ECG) until a beat is ultimately dropped, resulting in a cyclical pattern of conduction. Unlike other forms of heart block, Wenckebach often presents with a benign course, particularly in healthy individuals, although it can indicate underlying pathology in others.
Understanding the Electrical Conduction System
The human heart relies on an intricate electrical network to coordinate its rhythmic contractions. This system begins with the sinoatrial (SA) node, the natural pacemaker, which generates impulses that travel through the atria. The signal then reaches the atrioventricular (AV) node, where a critical delay occurs, allowing the atria to contract and fill the ventricles with blood before the ventricles themselves contract. In Wenckebach syndrome, this delay at the AV node becomes progressively longer with each successive heartbeat until the connection breaks, and the impulse fails to reach the ventricles.
The Physiology of Progressive Conduction Block
The hallmark of Mobitz Type I is the incremental prolongation of the PR interval. This occurs because the AV node tissue becomes progressively less responsive with each impulse, a phenomenon known as decremental conduction. Eventually, a P wave—the electrical signal representing atrial contraction—appears without a corresponding QRS complex—the signal for ventricular contraction—leading to a dropped beat. After this pause, the cycle resets, and the PR interval begins to lengthen again, creating the characteristic "crescendo-decrescendo" pattern observed on an ECG.
Causes and Risk Factors
While Wenckebach syndrome can occur in healthy young athletes or during sleep due to heightened vagal tone, it is frequently associated with identifiable medical conditions. The most common causes involve damage or inflammation to the conduction system, often stemming from coronary artery disease, myocardial infarction, or myocarditis. Additionally, certain medications, particularly beta-blockers, calcium channel blockers, and digoxin, can precipitate this type of block by further slowing conduction through the AV node.
Age-related degenerative changes in the conduction system
Acute myocardial infarction, particularly affecting the inferior wall of the heart
Inflammatory conditions such as Lyme disease or rheumatic fever
Metabolic imbalances, including severe hyperkalemia or hypothyroidism
Congenital heart defects
Symptoms and Clinical Presentation
Many individuals with Wenckebach syndrome remain entirely asymptomatic, with the condition discovered incidentally during a routine ECG or physical examination. When symptoms do occur, they are typically related to a temporary reduction in cardiac output due to the dropped beat. Patients may report sensations of lightheadedness, dizziness, or mild palpitations. In more severe cases, syncope, or fainting, can occur, although this is less common than with higher-grade heart blocks.
Diagnosis and ECG Findings
Diagnosis hinges primarily on the interpretation of a 12-lead ECG. Specific criteria must be met to classify a rhythm as Wenckebach syndrome. These include a progressively lengthening PR interval on consecutive beats, a subsequent dropped QRS complex, and a resultant pause that is shorter than the preceding PP interval. The PR interval resets after the dropped beat, and the cycle repeats. It is crucial to differentiate this from Mobitz Type II block, which carries a more ominous prognosis and often requires immediate intervention.
